Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis
Authors:
- Tiechin C. HoTHTiechin C. Ho
- Gregory J. AhmannGAGregory J. Ahmann
- Jerry A. KatzmannJKJerry A. Katzmann
- Philip R. GreippPGPhilip R. Greipp
- 1 October 1994
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 97 (4) , 374-378
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Elevated serum interleukin‐6 levels in patients with reactive thrombocytosisBritish Journal of Haematology, 1991
- Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1 β and interleukin-6 in the human hepatoma cell line PLC/PRF/5Biochemical Journal, 1991
- Interleukin-6 in clinical medicineAnnals of Hematology, 1991
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989
- Primary thrombocythaemia: diagnostic criteria and a simple scoring system for positive diagnosisBritish Journal of Haematology, 1989
- Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritisEuropean Journal of Immunology, 1988
- SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSESThe Lancet, 1987
- Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.Journal of Clinical Pathology, 1986
- The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: An analysis of 129 casesAmerican Journal of Hematology, 1985
- Cytogenetic studies on primary thrombocythaemiaHereditas, 1982